PE20040205A1 - Derivados de azepano como inhibidores de la quinasa akt1 - Google Patents
Derivados de azepano como inhibidores de la quinasa akt1Info
- Publication number
- PE20040205A1 PE20040205A1 PE2003000227A PE2003000227A PE20040205A1 PE 20040205 A1 PE20040205 A1 PE 20040205A1 PE 2003000227 A PE2003000227 A PE 2003000227A PE 2003000227 A PE2003000227 A PE 2003000227A PE 20040205 A1 PE20040205 A1 PE 20040205A1
- Authority
- PE
- Peru
- Prior art keywords
- azepan
- hydroxy
- alkyl
- derivatives
- isonicotinamide hydrochloride
- Prior art date
Links
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical class C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 title abstract 2
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 title 1
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- -1 ALKYL (1-4C) Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 150000003973 alkyl amines Chemical class 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical class [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- SFDJOSRHYKHMOK-UHFFFAOYSA-N nitramide Chemical compound N[N+]([O-])=O SFDJOSRHYKHMOK-UHFFFAOYSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A DERIVADOS AZEPANOS DE FORMULA I DONDE A ES UN CARBOCICLICO O HETEROCICLICO; B ES UN FENILO QUE PUEDE ESTAR SUSTITUIDO POR 1,2 O 3 SUSTITUYENTES COMO HALOGENO, ALQUILO(1-4C), TRIFLUOROMETILO, HIDROXILO, ALCOXILO(1-4C), NITRO, AMINO, AMINO(1-4C)ALQUILO, ALQUILAMINO(1-4C), ALCANOILAMINO(1-4C), TIOALQUILO(1-4C), ENTRE OTROS; (R1)n ES HALOGENO, ALQUILO(1-4C) O UN ALCOXILO(1-4C) Y n = 0-4.SON COMPUESTOS PREFERIDOS N-{(3R,4R)-4-[4-(2-FLUORO-6-HIDROXI-3-METOXI-BENZOIL)-BENZOILAMINO]-AZEPAN-3-IL}-ISONICOTINAMIDA HIDROCLORURO, N-{(3R,4R)-4-[4-(2-FLUORO-6-HIDROXI-3-METIL-BENZOIL)-BENZOILAMINO]-AZEPAN-3-IL}-ISONICOTINAMIDA HIDROCLORURO, N-{(3R,4R)-4-[4-(6-HIDROXI-3-METILSULFANIL-BENZOIL)-BENZOILAMINO]-AZEPAN-3-IL}-ISONICOTINAMIDA HIDROCLORURO, ENTRE OTROS. TAMBIEN SE REFIERE UN PROCEDIMIENTO PARA LA PREPARACION. LOS COMPUESTOS POSEEN ACTIVIDAD DE ANTIPROLIFERACION CELULAR Y MUESTRAN UN AUMENTO DE LA ESTABILIDAD EN PLASMA Y PUEDEN SER UTILES PARA LA TERAPIA Y PEVENCION DEL CANCER
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02005287 | 2002-03-12 | ||
| EP02006648 | 2002-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040205A1 true PE20040205A1 (es) | 2004-04-08 |
Family
ID=27806513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000227A PE20040205A1 (es) | 2002-03-12 | 2003-03-07 | Derivados de azepano como inhibidores de la quinasa akt1 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6887864B2 (es) |
| EP (1) | EP1487819A2 (es) |
| JP (1) | JP2005524671A (es) |
| CN (1) | CN1321116C (es) |
| AR (1) | AR038916A1 (es) |
| AU (1) | AU2003218715A1 (es) |
| CA (1) | CA2478276A1 (es) |
| PA (1) | PA8568901A1 (es) |
| PE (1) | PE20040205A1 (es) |
| TW (1) | TW200401644A (es) |
| UY (1) | UY27717A1 (es) |
| WO (1) | WO2003076429A2 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1865978A4 (en) | 2005-03-21 | 2012-01-25 | Univ Columbia | NEW NEURONAL PAINWAY |
| US8846742B2 (en) * | 2006-02-14 | 2014-09-30 | The Trustees Of Columbia University In The City Of New York | Neuronal pain pathway modulators |
| RU2016105998A (ru) | 2013-07-23 | 2017-08-29 | Ф.Хоффманн-Ля Рош Аг | Конверсия на основе малых молекул соматических клеток в клетки нейрального гребня |
| EP3473628B1 (en) * | 2016-06-16 | 2019-12-11 | Harbin Zhenbao Pharmaceutical Co., Ltd. | Dihydropyrazole azepine compound serving as akt inhibitor |
| AU2018359413B2 (en) * | 2017-10-31 | 2023-11-23 | University Of Miami | Kinase inhibitors for the treatment of central and peripheral nervous system disorders |
| CN107759606B (zh) * | 2017-11-29 | 2018-12-21 | 南京诺希生物科技有限公司 | 具有抗肿瘤活性的氮杂环烯烃并二氮卓药物分子及其制备方法 |
| JP7101781B2 (ja) | 2017-12-13 | 2022-07-15 | ハルビン チェンバオ ファーマシューティカル カンパニー リミテッド | Ａｋｔ阻害剤としての塩形態及びその結晶形態 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86632A0 (en) | 1987-06-15 | 1988-11-30 | Ciba Geigy Ag | Derivatives substituted at methyl-amino nitrogen |
| EP0687249A1 (en) | 1993-03-03 | 1995-12-20 | Eli Lilly And Company | Balanoids |
| CN1050844C (zh) | 1993-12-07 | 2000-03-29 | 伊莱利利公司 | 蛋白激酶ｃ抑制剂 |
| AU686691B2 (en) | 1994-01-12 | 1998-02-12 | F. Hoffmann-La Roche Ag | Novel azepanes and homologs thereof |
| US5583221A (en) | 1994-05-04 | 1996-12-10 | Eli Lilly And Company | Substituted fused and bridged bicyclic compounds as therapeutic agents |
| TW339325B (en) | 1995-07-05 | 1998-09-01 | Hoffmann La Roche | Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| EP0802190A1 (de) | 1996-04-17 | 1997-10-22 | F. Hoffmann-La Roche Ag | Verfahren zur Herstellung von Azepinen |
| JP2000186092A (ja) | 1998-12-22 | 2000-07-04 | Kyowa Hakko Kogyo Co Ltd | Ｕｃｎ−０１の製造法 |
-
2003
- 2003-03-06 US US10/383,111 patent/US6887864B2/en not_active Expired - Fee Related
- 2003-03-07 PE PE2003000227A patent/PE20040205A1/es not_active Application Discontinuation
- 2003-03-07 TW TW092104923A patent/TW200401644A/zh unknown
- 2003-03-10 AU AU2003218715A patent/AU2003218715A1/en not_active Abandoned
- 2003-03-10 JP JP2003574646A patent/JP2005524671A/ja active Pending
- 2003-03-10 CN CNB038056763A patent/CN1321116C/zh not_active Expired - Fee Related
- 2003-03-10 EP EP03711955A patent/EP1487819A2/en not_active Withdrawn
- 2003-03-10 CA CA002478276A patent/CA2478276A1/en not_active Abandoned
- 2003-03-10 WO PCT/EP2003/002412 patent/WO2003076429A2/en active Application Filing
- 2003-03-10 AR ARP030100809A patent/AR038916A1/es not_active Application Discontinuation
- 2003-03-11 UY UY27717A patent/UY27717A1/es not_active Application Discontinuation
- 2003-03-11 PA PA20038568901A patent/PA8568901A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1487819A2 (en) | 2004-12-22 |
| US20030181716A1 (en) | 2003-09-25 |
| CN1321116C (zh) | 2007-06-13 |
| CN1639151A (zh) | 2005-07-13 |
| AU2003218715A1 (en) | 2003-09-22 |
| US6887864B2 (en) | 2005-05-03 |
| PA8568901A1 (es) | 2003-12-10 |
| UY27717A1 (es) | 2003-09-30 |
| WO2003076429A2 (en) | 2003-09-18 |
| AU2003218715A8 (en) | 2003-09-22 |
| WO2003076429A3 (en) | 2004-01-08 |
| CA2478276A1 (en) | 2003-09-18 |
| JP2005524671A (ja) | 2005-08-18 |
| TW200401644A (en) | 2004-02-01 |
| AR038916A1 (es) | 2005-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0202463D0 (sv) | Novel compounds | |
| BR0307351A (pt) | Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto | |
| DE602004011199D1 (de) | 5-phenylthiazolderivate und deren verwendung als p13-kinase-inhibitoren | |
| BR0313160A (pt) | Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto | |
| BR0312464A (pt) | Inibidores de tirosina quinases | |
| ECSP045253A (es) | Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa | |
| PE20040458A1 (es) | Piridinas sustituidas con actividad anti-angiogenica | |
| ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
| AR031248A1 (es) | Compuestos de ditosilato de quinazolina, composicion farmaceutica, metodo de tratamiento y uso en terapia y proceso para la preparacion de dichos compuestos | |
| ES2128092T3 (es) | Derivados de anilina. | |
| PE20011066A1 (es) | PIRIDO [2,3-d] PIRIMIDIN-2,7-DIAMINAS INHIBIDORES DE CINASAS | |
| BRPI0514371A (pt) | 2, 4 di (aminofenil) pirimidina como inibidores de plk | |
| NO20021328L (no) | Pyrazolopyrimidier som terapeutiske midler | |
| NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
| PL378064A1 (pl) | Pirymidyny i triazyny hamujące replikację wirusa HIV | |
| BRPI0410760A (pt) | compostos, processo para fabricação dos mesmos, composições farmacêuticas e uso deste compostos | |
| UY28150A1 (es) | Agentes terapeuticos | |
| BRPI0412999A (pt) | 2-aminotetralina substituìda para tratamento de depressão | |
| PE20070359A1 (es) | Inhibidores de pirimidinilpirazol de aurora quinasas | |
| HRP20050830A2 (en) | Non-nucleoside reverse transcriptase inhibitors i for treating hiv mediated diseases | |
| UA94570C2 (en) | Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase | |
| SG171471A1 (en) | New benzimidazole derivatives | |
| SE0403171D0 (sv) | New compounds | |
| BRPI0407841A (pt) | inibidores heterocìclicos de quinase | |
| NO20050088L (no) | Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |